The text provided includes information from Lam Research Corporation's financial statements for the quarter ended September 25, 2022. It covers various aspects such as revenue disaggregation, financial instruments and fair value, stock repurchase programs, leases, commitments, contingencies, warranties, intangible assets, and accumulated other comprehensive loss. Additionally, it outlines details about the Company's operations, income, expenses, equity-based compensation, tax expenses, net income per share, and more. The content offers a comprehensive view of the financial status, risks, and strategic decisions of Lam Research Corporation.
The text provided discusses Management's Discussion and Analysis of Financial Condition and Results of Operations for Lam Research Corporation. The company's focus on forward-looking statements, financial results, revenue breakdown, gross margin, operating expenses, recent performance, income tax expense, critical accounting policies, liquidity, capital resources, and cash flow from operating, investing, and financing activities are detailed. The company experienced revenue growth, margin improvements, and increased cash balances, considering challenges such as inflationary pressures and regulatory impacts on China trade. The text highlights the company's strategies to navigate the semiconductor industry's evolving landscape, reflecting the potential impact of external factors like the COVID-19 pandemic on future financial performance and liquidity management.
The text outlines that for detailed information on financial market risks like interest rates, equity security prices, and foreign currency exchange rates, readers should refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" in the 2022 Form 10-K. The exposure to market risk has not significantly changed since June 26, 2022.
The company maintains disclosure controls and procedures and internal controls over financial reporting to comply with Exchange Act regulations, recognizing that controls can only provide reasonable assurance and may not be completely effective all the time. An evaluation was carried out by management on the effectiveness of these controls, concluding that they are effective at the reasonable assurance level. There have been no material changes in internal control over financial reporting in the recent fiscal quarter, and the company will continue monitoring and enhancing controls to ensure senior management has timely access to material information that could impact the business.
The text is a reference to a specific section titled "Legal Proceedings" within Note 13 "Commitments and Contingencies" in the Condensed Consolidated Financial Statements in a quarterly report on Form 10-Q. It implies that more detailed information regarding legal matters and obligations can be found within that section.
The text provided discusses various risk factors that Lam Research Corporation faces. These risks include the variability in market demand due to the semiconductor industry's nature, challenges in strategic resource allocation decisions, potential declines in the semiconductor industry affecting financial conditions, reliance on key customers, competitive pressures, customer retention challenges, technological advancements, and the impact of the COVID-19 pandemic. Additionally, the company faces risks related to supply chain disruptions, cybersecurity threats, the complex competitive environment, regulatory and legal risks, financial risks related to market volatility, debt obligations, possible impairments, dependence on goodwill, and the potential impact on capital availability due to dividend payments and share repurchases. These factors may adversely affect the company's financial condition, operational performance, and ability to raise capital or comply with regulatory requirements.
The text discusses the unregistered sales of equity securities and the use of proceeds for repurchases of company shares. The Board of Directors authorized management to repurchase up to an additional $5.0 billion of Common Stock, with repurchases conducted on the open market or as private purchases, subject to compliance with applicable law. The repurchase program has no termination date, and share repurchases were made in specific periods. An accelerated share repurchase agreement was also entered into in June 2022 with financial institutions to repurchase $500 million of Common Stock. The final settlement of this agreement yielded approximately 433 thousand additional shares at a weighted-average price of $435.20.
The text states that there are no defaults upon senior securities.
The text provided states that there are no mine safety disclosures applicable.
The text provided is a statement from Lam Research Corporation's 2023 Q1 10-Q filing indicating that there is no additional information to report in the "Other Information" section.
The text provides exhibit descriptions related to certifications and documents filed by Lam Research Corporation for the 2023 Q1 10-Q report. It includes certifications by the Principal Executive Officer and the Principal Financial Officer, Inline XBRL documents, cover page interactive data file, and signatures indicating compliance with the Securities Exchange Act of 1934. The report was signed by Douglas R. Bettinger, the Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer of Lam Research Corporation on October 24, 2022.
